ROVIDA, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.128
EU - Europa 7.864
AS - Asia 4.498
SA - Sud America 596
Continente sconosciuto - Info sul continente non disponibili 256
AF - Africa 109
OC - Oceania 58
Totale 23.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.901
PL - Polonia 2.144
RU - Federazione Russa 2.064
IT - Italia 1.603
SG - Singapore 1.211
CN - Cina 1.048
HK - Hong Kong 645
SE - Svezia 488
IE - Irlanda 478
VN - Vietnam 468
BR - Brasile 448
KR - Corea 312
DE - Germania 220
FR - Francia 220
IN - India 195
FI - Finlandia 188
GB - Regno Unito 160
JO - Giordania 136
BD - Bangladesh 135
CA - Canada 126
JP - Giappone 88
UA - Ucraina 81
ID - Indonesia 60
NL - Olanda 58
AU - Australia 57
AR - Argentina 52
CH - Svizzera 41
MX - Messico 41
EC - Ecuador 33
TR - Turchia 33
CI - Costa d'Avorio 29
IQ - Iraq 25
BE - Belgio 22
TW - Taiwan 21
ZA - Sudafrica 21
ES - Italia 19
VE - Venezuela 19
PK - Pakistan 17
AT - Austria 16
CO - Colombia 15
MA - Marocco 13
NG - Nigeria 13
CR - Costa Rica 12
PH - Filippine 12
JM - Giamaica 11
MK - Macedonia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
UZ - Uzbekistan 9
CL - Cile 8
EG - Egitto 8
PE - Perù 8
IL - Israele 7
LK - Sri Lanka 7
LT - Lituania 7
RO - Romania 7
IR - Iran 6
KE - Kenya 6
MY - Malesia 6
AL - Albania 5
DZ - Algeria 5
LB - Libano 5
PY - Paraguay 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AZ - Azerbaigian 4
BJ - Benin 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HU - Ungheria 4
KW - Kuwait 4
NI - Nicaragua 4
PR - Porto Rico 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PT - Portogallo 3
SV - El Salvador 3
TN - Tunisia 3
AM - Armenia 2
BS - Bahamas 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
MM - Myanmar 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 23.236
Salva come PNG Salva come JPEG
Città #
Warsaw 2.141
Santa Clara 2.110
Ashburn 1.304
Singapore 893
Fairfield 754
Chandler 538
Hong Kong 535
Dublin 473
Woodbridge 370
San Jose 339
Seattle 333
Seoul 302
Florence 293
Cambridge 290
Houston 275
Milan 275
Beijing 268
Wilmington 243
Council Bluffs 216
Ann Arbor 205
Jacksonville 151
Rome 128
Hefei 127
Buffalo 120
Ho Chi Minh City 120
Los Angeles 120
Princeton 119
Lawrence 110
Lauterbourg 109
Altamura 105
Boston 96
Dallas 88
Munich 88
The Dalles 86
Hanoi 85
Tokyo 75
New York 73
Dong Ket 72
Boardman 71
Mumbai 71
Paris 70
Moscow 68
Shanghai 68
Helsinki 59
San Diego 58
Kent 57
Melbourne 55
Jakarta 46
São Paulo 41
Medford 40
Falls Church 39
Naples 38
Orem 37
Pune 34
Turin 31
Turku 31
Frankfurt am Main 30
London 30
Abidjan 29
Toronto 29
Bern 28
Redondo Beach 28
Guangzhou 27
Chicago 26
Phoenix 26
Bologna 22
Brussels 22
Clifton 22
Norwalk 21
Portsmouth 21
Montreal 20
Ottawa 20
Columbus 19
Da Nang 19
Lappeenranta 18
Chennai 17
Atlanta 16
Bari 16
Figino 15
Yubileyny 15
Brooklyn 14
Redwood City 14
Rio de Janeiro 14
Miano 13
Palermo 13
Siena 13
Tianjin 13
Daan 12
Dearborn 12
Haiphong 12
Hangzhou 12
Stockholm 12
Vienna 12
Abuja 11
Andover 11
Denver 11
Guayaquil 11
Quito 11
San José 11
Baghdad 10
Totale 15.721
Salva come PNG Salva come JPEG
Nome #
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 389
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 377
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 363
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 353
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 346
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 344
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 343
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 341
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 340
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 338
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 335
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 329
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 324
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 298
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 297
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 292
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 274
Impact of ERK5 on the Hallmarks of Cancer 269
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 259
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 257
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 257
Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation 253
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 253
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 248
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 236
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 234
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 233
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 230
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 230
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 218
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 217
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 216
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 210
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 209
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 208
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 207
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 206
Fatty acids regulate the biology of cholangiocarcinoma cells 204
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 204
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 202
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 200
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 200
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 199
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 198
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 197
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 196
ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2 191
Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? 191
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 191
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 190
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 187
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 187
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 185
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 185
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 185
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 184
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 184
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 184
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 183
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 183
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 181
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 180
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 179
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 179
BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake 177
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 175
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 172
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress 171
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 171
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 168
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 168
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 167
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 166
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 166
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 163
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 161
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 161
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 160
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 158
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 156
Tryptophan availability selectively limits NO-synthase induction in macrophages. 154
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 154
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 153
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 152
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 152
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 150
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 150
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 150
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 150
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 150
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 149
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 146
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 146
L’oncogene fes e la fosfotirosino-fosfatasi citosolica a basso peso molecolare interferiscono con la proliferazione e l’adesione cellulare 145
Latent-transforming growth factor β-binding protein 1/Transforming growth factor β1 complex drives antitumoral effects upon ERK5 targeting in melanoma 145
ERK5 inhibition elicits cellular senescence in human melanoma cells 144
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 142
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 141
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 138
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma 136
Totale 21.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022881 0 66 44 56 50 54 49 54 68 59 140 241
2022/20232.234 189 366 125 159 155 382 299 142 284 16 67 50
2023/2024886 30 84 122 35 58 114 54 200 25 39 86 39
2024/20256.099 218 581 355 897 1.800 826 94 344 285 219 248 232
2025/20267.129 769 860 491 493 802 293 822 375 491 514 259 960
2026/2027443 272 171 0 0 0 0 0 0 0 0 0 0
Totale 23.509